Asymptotically Optimal Methods of Early Change-Point Detection
- 期刊名称Sequential Analysis
- 作者Brodsky, Boris; Darkhovsky, Boris
- 卷第32卷
- 期第2期
- 印刷ISSN0747-4946
- 电子ISSN1532-4176
- 文件大小219.95KB
- 发表时间2013-04-15
- DOI10.1080/07474946.2013.774611
- 页码158-181
The cardiovascular safety of tadalafilReffelmann, Thorsten; Kieback, Arne; Kloner, Robert A · Expert Opinion on Drug Safety · 2008
Blood supply of the graft after cellular cardiomyoplastyReffelmann, Thorsten; Kloner, Robert A · Regenerative Medicine · 2010
Ranolazine: an anti-anginal drug with further therapeutic potentialReffelmann, Thorsten; Kloner, Robert A · Expert Review of Cardiovascular Therapy · 2010
Vardenafil: a selective inhibitor of phosphodiesterase-5 for the treatment of erectile dysfunctionReffelmann, Thorsten; Kloner, Robert A · Expert Opinion on Pharmacotherapy · 2007
Intracoronary blood- or bone marrow-derived cell transplantation in patients with ischemic heart diseaseReffelmann, Thorsten; Kloner, Robert A · Regenerative Medicine · 2009
Nicotinic acid: clinical considerationsKei, Anastazia; Elisaf, Moses S · Expert Opinion on Drug Safety · 2012
Drug safety evaluation of rosuvastatinToth, Peter P; Dayspring, Thomas D · Expert Opinion on Drug Safety · 2011
Gastrointestinal side effects of drugsMakins, Richard; Ballinger, Anne · Expert Opinion on Drug Safety · 2003
Capecitabine and hand–foot syndromeSaif, Muhammad Wasif · Expert Opinion on Drug Safety · 2011
Immune hemolytic anemia caused by drugsGarratty, George · Expert Opinion on Drug Safety · 2012
Thiazolidinedione safetyKung, Jacqueline; Henry, Robert R · Expert Opinion on Drug Safety · 2012
The safety of thiazolidinedionesTolman, Keith G · Expert Opinion on Drug Safety · 2011
Drug-induced immune hemolytic anemiaSalama, Abdulgabar · Expert Opinion on Drug Safety · 2009